Hospital Findr / Find Doctors / New York / Dr. Lila S E Nachtigall

Dr. Lila S E Nachtigall, MD

Endocrinology, Diabetes & Metabolism, Reproductive Endocrinology, Obstetrics & Gynecology
65 years of experience
Nyu Tisch Hospital 550 1st Ave, New York, NY 10016
(646) 929-7870

Overview
Location
Expertise
Insurance

Brief Intro

Over the past 20 years Lila E. Nachtigall, M.D. has been involved in three areas of investigation. These include: 1) evaluating whether estrogen replacement therapy (ERT) reduces the risk of coronary heart disease and other cardiovascular in women; 2) determining whether estrogen replacement alone or estrogen progesterone replacement reduces the incidence of osteoporosis-related fractures and hip fractures; and 3) whether ERT increases the risk of endometrial cancer and whether progestin and estrogen replacement therapies (PERT) increase breast cancer risk. Studies in these specific areas have been ongoing at NYU Medical Center since 1967. Dr. Nachtigall conducted a comprehensive ten year prospective double blind placebo controlled study of estrogen replacement therapy and the relationship to carcinoma, cardiovascular disease, and osteoporosis in a sample of hospitalized women. From the 300 women recruited, 168 were followed as matched pairs. This study was the first to demonstrate the increased survival of patients on ERT, of lipid patterns as a significant risk factor, and of a reduction in breast cancer incidence in treated patients as compared to the controls. Moreover, a ten year follow-up with single photon densitometer measurements found continued increase in bone density in treated women who had their last menstrual period within three years or less, while those on placebo continued to lose bone. In addition, treated women who had their last menstrual period more than three years previously, kept their bone at a steady level, while their placebo controlled matched pairs continued to lose bone. Dr. Nachtigall subsequently conducted a 22 year follow-up on these studies, losing only five patients to follow-up or breast cancer. Studies are continuing to address such issues as the efficacy of transdermal versus oral estrogen, the use of progesterone in prevention of endometrial cancer, the ability to decrease the side effects of progesterone therapy and on cardiovascular disease in older women, with and without hormones.

Education Background

RESIDENCY

New York University

MEDICAL SCHOOL

New York Medical College - 1960

Languages Spoken

English

Location & Hours

Nyu Tisch Hospital
550 1st Ave, New York, NY 10016

Specialties Treated

Reproductive Endocrinology
Endocrinology, Diabetes & Metabolism
Obstetrics & Gynecology

Conditions Addressed

Female Infertility

Insurance Accepted

* Insurance information may change frequently. Please verify directly with the provider (doctor/clinic).

UnitedHealthcare
AARP
Aetna
Horizon Blue Cross Blue Shield of New Jersey
Cigna
UnitedHealthcare Oxford
EmblemHealth
Medicare

Cancer 43
Cardiology, Heart & Vascular Surgery 31
Orthopedics 75
Neurology & Neurosurgery 60
Gastroenterology & GI Surgery 75
Pulmonology & Lung Surgery 91
Diabetes & Endocrinology 44
Children's Hospital 22
Urology 87
Psychiatry 103
Geriatrics 82
Rehabilitation 38
Obsterics & Gynecology 17
Ophthalmology 4
Ear, Nose & Throat 11
Rheumatology 2
Long Term Care 3
Maternity Care (Uncomplicated Pregnancy) 60